Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial

Illerhaus, G. and Cwynarski, K. and Pulczynski, E. and Ponzoni, M. and Deckert, M. and Politi, L. S. and Fox, C. P. and La Rose, P. and Ambrosetti, A. and Roeth, A. and Hemmaway, A. and Ilariucci, F. and Linton, K. M. and Soffietti, R. and Pukrop, T. and Binder, M. and Balzarotti, M. and Fabbri, A. and Johnson, P. and Gorlov, J. S. and Cavalli, F. and Finke, J. and Schorb, E. and Reni, M. and Zucca, E. and Ferrer, A. J. M. (2015) Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial. Oncology Research and Treatment, 38 (Suppl5). p. 177. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 26 Aug 2020 06:12
Last Modified: 26 Aug 2020 06:12
URI: https://pred.uni-regensburg.de/id/eprint/4682

Actions (login required)

View Item View Item